13F-HR filed by Sarissa Capital Management LP
Sarissa Capital Management LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 14 holding rows worth $1,043,262,000.
- Accession
- 0001567619-21-010558
- Filer
- CIK 1577524
- Filed
- 2021-05-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 14 entries on the cover page, a total value of $1,043,262,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,043,262,000 with VALUE read as thousands by filing date, 13F file number 028-15935. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 16,390,000 | $183,240,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 643,000 | $179,879,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 2,697,400 | $174,332,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 7,950,000 | $148,506,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 650,440 | $99,458,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 7,637,700 | $77,675,000 | thousands by filing date | |
| INNOVIVA INC | 45781M101 | COM | 6,414,000 | $76,647,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 4,005,600 | $64,810,000 | thousands by filing date | |
| VOR BIOPHARMA INC | 929033108 | COM | 707,010 | $30,472,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W110 | *W EXP 10/23/202 | 3,333,333 | $4,999,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K200 | COM NEW | 1,851,851 | $2,888,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,000 | $171,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,000 | $164,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 950 | $21,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-21-010558 | this filing | 2021-05-17 | acceptance time not in the bulk data set |